|
2-deoxystreptamine catabolic process
|
GO_1901743 |
[The chemical reactions and pathways resulting in the breakdown of 2-deoxystreptamine.] |
|
positive regulation of SREBP signaling pathway
|
GO_2000640 |
[Any process that activates or increases the frequency, rate or extent of the SREBP signaling pathway.] |
|
regulation of SREBP signaling pathway
|
GO_2000638 |
[Any process that modulates the frequency, rate or extent of the SREBP signaling pathway.] |
|
2-deoxystreptamine biosynthetic process
|
GO_1901744 |
[The chemical reactions and pathways resulting in the formation of 2-deoxystreptamine.] |
|
obsolete prephenate(2-) metabolic process
|
GO_1901745 |
[OBSOLETE. The chemical reactions and pathways involving prephenate(2-).] |
|
prephenate(2-) catabolic process
|
GO_1901746 |
[The chemical reactions and pathways resulting in the breakdown of prephenate(2-).] |
|
beta1-adrenergic receptor activity
|
GO_0004940 |
[Combining with epinephrine or norepinephrine to initiate a change in cell activity via activation of a G protein, with pharmacological characteristics of beta1-adrenergic receptors.] |
|
beta-adrenergic receptor activity
|
GO_0004939 |
[Combining with epinephrine or norepinephrine to initiate a change in cell activity via activation of a G protein, with pharmacological characteristics of beta-adrenergic receptors; the activity involves transmitting the signal to the Gs alpha subunit of a heterotrimeric G protein.] |
|
prephenate(2-) biosynthetic process
|
GO_1901747 |
[The chemical reactions and pathways resulting in the formation of prephenate(2-).] |
|
beta2-adrenergic receptor activity
|
GO_0004941 |
[Combining with epinephrine or norepinephrine to initiate a change in cell activity via activation of a G protein, with pharmacological characteristics of beta2-adrenergic receptors.] |
|
obsolete leukotriene D4 metabolic process
|
GO_1901748 |
[OBSOLETE. The chemical reactions and pathways involving leukotriene D4.] |
|
GO_0004942
|
GO_0004942 |
|
|
leukotriene D4 catabolic process
|
GO_1901749 |
[The chemical reactions and pathways resulting in the breakdown of leukotriene D4.] |
|
leukotriene catabolic process
|
GO_0036100 |
[The chemical reactions and pathways resulting in the breakdown of a leukotriene, a pharmacologically active substance derived from a polyunsaturated fatty acid, such as arachidonic acid.] |
|
GO_0004943
|
GO_0004943 |
|
|
GO_0004944
|
GO_0004944 |
|
|
angiotensin type II receptor activity
|
GO_0004945 |
[An angiotensin receptor activity that acts via Gi protein coupling and cGMP (NO) generation, and may also act via additional signaling mechanisms.] |
|
angiotensin receptor activity
|
GO_0001595 |
[Combining with angiotensin to initiate a change in cell activity.] |
|
bombesin receptor activity
|
GO_0004946 |
[Combining with bombesin to initiate a change in cell activity.] |
|
neuropeptide receptor activity
|
GO_0008188 |
[Combining with a neuropeptide to initiate a change in cell activity.] |